Retinal Ganglion Cell Protection in normal tension glaucoma mouse model by Geranylgeranylacetone
| Project/Area Number |
23592548
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Multi-year Fund |
|---|
| Section | 一般 |
|---|
| Research Field |
Ophthalmology
|
|---|
| Research Institution | Hokkaido University |
|---|
Principal Investigator |
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KITAICHI Nobuyoshi 北海道大学, 大学院医学研究科, 客員教授 (00183898)
北市 伸義 北海道大学, 医学(系)研究科(研究院), 客員教授 (40431366)
|
|---|
| Project Period (FY) |
2011 – 2013
|
| Project Status |
Completed (Fiscal Year 2013)
|
| Budget Amount *help |
¥5,070,000 (Direct Cost: ¥3,900,000、Indirect Cost: ¥1,170,000)
Fiscal Year 2013: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2012: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
|---|
| Keywords | 眼細胞生物学 / 神経保護 / 国際情報交換 / 細胞・組織 |
|---|
| Research Abstract |
To investigate the cytoprotective effect of geranylgeranylacetone (GGA) on retinal ganglion cell (RGC) degeneration using a normal tension glaucoma (NTG) mouse model, which lacks glutamate/aspartate transporter (GLAST) and demonstrates spontaneous RGC and optic nerve degeneration without elevated intraocular pressure (IOP).The number of RGC of GLAST+/- mice significantly decreased, as compared to that of littermate control mice. RGC loss was suppressed by administration of GGA in a dose-dependent manner. Following GGA administration, HSP70 was significantly up-regulated, and activities of caspase-9 and -3 were suppressed. HSP70 is a favorable target to suppress RGC degeneration, and thus GGA may be applicable for NTG as a promising therapeutics.
|
Report
(4 results)
Research Products
(3 results)
